Back to Search Start Over

MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA.

Authors :
Ruan, J.
Leonard, J.P.
Coleman, M.
Rutherford, S.
Van Besien, K.
Rodriguez, A.
Benderoff, L.
Mehta‐Shah, N.
Moskowitz, A.
Sokol, L.
Cerchietti, L.
Inghirami, G.
Martin, P.
Source :
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p560-561, 2p
Publication Year :
2019

Subjects

Subjects :
AZACITIDINE
T-cell lymphoma
THERAPEUTICS

Details

Language :
English
ISSN :
02780232
Volume :
37
Database :
Complementary Index
Journal :
Hematological Oncology
Publication Type :
Academic Journal
Accession number :
137029501
Full Text :
https://doi.org/10.1002/hon.8_2632
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details